Rhenman & Partners Asset Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-40,000
| Closed | -$371K | – | 103 |
|
2017
Q2 | $371K | Hold |
40,000
| – | – | 0.05% | 95 |
|
2017
Q1 | $371K | Hold |
40,000
| – | – | 0.06% | 93 |
|
2016
Q4 | $335K | Hold |
40,000
| – | – | 0.06% | 93 |
|
2016
Q3 | $275K | Hold |
40,000
| – | – | 0.04% | 96 |
|
2016
Q2 | $198K | Hold |
40,000
| – | – | 0.04% | 95 |
|
2016
Q1 | $386K | Buy |
+40,000
| New | +$386K | 0.08% | 90 |
|